AHA: HDL Drug Fails for Prevention

Published November 9, 2012

AHA: HDL Drug Fails for Prevention

Filed under: Denver Drug Treatment

LOS ANGELES — The novel drug dalcetrapib substantially boosts HDL levels but with no impact on outcomes and a signal for blood pressure problems, according to results from a phase III trial in patients with recent acute coronary syndromes. … and …
Read more on MedPage Today

Diabetes and depression: How one affects the other

Filed under: Denver Drug Treatment

Satish Garg, MD, Editor-in-Chief of Diabetes Technology & Therapeutics and Professor of Medicine and Pediatrics at the University of Colorado Denver wrote in a May, 2012 press release, "We still do not know which comes first. This needs further … It …
Read more on eMaxHealth

Election 2012: How pot, porn and punishment initiatives fared with voters

Filed under: Denver Drug Treatment

In a statement issued after the votes were counted in Colorado and Washington, Ethan Nadelmann, the executive director of the Drug Policy Alliance, a non-profit advocacy group that supports the reform of drug laws, touted the "historic significance" of …
Read more on CBS News